FDA inspection

Spectrum Pharmaceuticals, Inc.: FDA inspection ending Feb 12, 2020

FDA inspection 1117779 · Voluntary Action Indicated (VAI) · Boston, MA

Key facts

Inspection ID 1117779
Firm Spectrum Pharmaceuticals, Inc.
FEI number 3005383580
Address 157 Technology Dr
City Boston
State MA
ZIP 02110
Country United States
Fiscal year 2020
Inspection end date Feb 12, 2020
Classification Voluntary Action Indicated (VAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections